Journal
ACS NANO
Volume 10, Issue 8, Pages 7582-7597Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.6b02627
Keywords
colloidal gold; cooperativity; multivalence; nanomedicine; misfolded proteins; protein fibrillization; neurodegenerative diseases
Categories
Funding
- Faculty of Chemistry, University of Duisburg-Essen
- Evonik Industries
- Forschungskommission of the Heinrich-Heine University Dusseldorf-Medical Faculty [54/2013]
- Helmholtz Association
Ask authors/readers for more resources
Therapeutically active small molecules represent promising nonimmunogenic alternatives to antibodies for specifically targeting disease relevant receptors. However, a potential drawback compared to antibody-antigen interactions may be the lower affinity of small molecules toward receptors. Here, we overcome this low-affinity problem by coating the surface of nanoparticles (NPs) with multiple ligands. Specifically, we explored the use of gold and platinum nanoparticles to increase the binding affinity of A beta-specific small molecules to inhibit A beta peptide aggregation into fibrils in vitro. The interactions of bare NPs, free ligands, and NP-bound ligands with A beta are comprehensively studied via physicochemical methods (spectroscopy, microscopy, immunologic tests) and cell assays. Reduction of thioflavin T fluorescence, as an indicator for beta-sheet content, and inhibition of cellular A,6 excretion are even more effective with NP-bound ligands than with the free ligands. The results from this study may have implications in the development of therapeutics for treating Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available